News from Manufacturers

News from manufacturers of finished drugs, active ingredients and substances etc. Biotechnological production news.

New product of R-Pharm will reduce the cost of HCV treatment

r-pharm
On April 25, Vladimir Putin met the representatives of businesses in the Yaroslavl region. The event was attended by Vasily Ignatiev, the CEO of R-Pharm Group. The CEO of R-Pharm mentioned the suppor...

New technology will make vaccines quality control in Russia 300 times faster

vaccines
National Immunobiological Company (Nacimbio) introduces a new technology to control the quality of anti-TB vaccines that cuts the period of procedure from one month to 1.5 hours. The technology is dev...

Nacimbio and Nanolek announced cooperation in vaccine manufacturing

nanolek
Nacimbio and Nanolec intend to combine their competencies and efforts in the development and organization of a full technological cycle for manufacturing immunobiological medicines at the facilities o...

ZiO-Zdorovie continue technical re-equipment and modernization of production

zio-zdorovje
According to the administration of Podolsk Municipal District, the Ministry of Investments and Innovations of the Moscow Region has approved a list of 16 systemically important enterprises that have s...

New Pharmasyntez plant in Bratsk plans to master up to 45 types of substances

pharmasintez
The Bratsk pharmaceutical substances plant (LLC Bratskhimsyntez) which is scheduled for launch this fall, is among the investment projects of Pharmasynthez in the Irkutsk region. The plant is expected...

BIOCAD’s first biosimilar of interferon beta-1a approved in Russia

biocad
The Ministry of Health (MoH) of the Russian Federation has awarded Biocad marketing authorization for its interferon beta-1a biosimilar, a knockoff of Biogen's Rebif® that is a key component in treatm...

BIOCAD will invest 20 bln rubles in production development

biocad
In the near 3-5 years BIOCAD Company is going to invest 20 bln rubles in development of its production facilities in St.Petersburg. Biotechnological company BIOCAD has started several projects at once...

Saneca will drive R&D Initiative following €1.5 million funding

saneca
Contract development and manufacturing organization (CDMO) Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (...

Pharmaceuticals requiring complex synthesis set a promising niche in Russia

complex-synthez
It seems like pharmaceutical Russia has already found its niche, at least the most promising national manufacturers get concentrated on development and marketing of highly-tailored medicinal drugs int...

Akrikhin has started a full-cycle production of Simvastatin

akrikhin
AKRIKHIN JSC has successfully launched a full-cycle production of simvastatin (zocor), a medication intended for prevention and treatment of cardiovascular diseases that was developed by MSD — an inte...

A pilot batch of innovative drug was manufactured at the production site of Dubna-Biopharm

dubna-biofarm
The first batch of innovative medicinal product, produced at the new pilot-line production site of the company Dubna-Biopharm, the resident of Special Economic Zone (SEZ) Dubna, appeared in the pharma...

Quadrivalent influenza vaccine will be available in Russia by 2019

Russian manufacturers of pharmaceuticals are ready to present a new quadrivalent influenza vaccine protecting against four different flu strains before the start of epidemic season in 2019. “It is ...

JSC Pharmasyntez has invested over 2 billion rubles in two new production facilities

New investment projects initiated by the largest enterprises operating in Irkutsk region will be implemented this year. On February 9, Sergey Levchenko, the Governor of Irkutsk region, made the statem...

Microgen is ready to market a unique bacteriophage

Combined bacteriophage preparation "Enterobacter multivalent purified" intended for treatment and prevention of infections caused by Enterobacter species has successfully passed the phase II clinical ...

IDF loan will enable Petrovax Pharm to increase production of substances and finished drugs

"The Advisory Committee of the Industrial Development Fund approved the first projects in 2017. Out of total 1.3 billion rubles for the implementation of the projects, 600 million rubles have to be co...

Petrovax Pharm is expanding production capacities

NPO Petrovax Pharm will increase the manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms (tablets and suppositories) of original local pharmaceuticals. It is planned to i...